Back to MW Marshall Wace, LLP

PRAXPRAX

Showing 7 of 10 quarters

Position history for MWMarshall Wace, LLP's holdings in Praxis Precision Medicines, Inc.

Yes. Marshall Wace holds 137,008 shares of PRAX (Praxis Precision Medicines), worth $45.9M, as of its Q2 2026 13F filing. It increased the position from 45,149 shares in Q1 2026. Marshall Wace has held PRAX since Q3 2025, across 4 quarterly 13F filings.

Current Value

$45.9M

Current Shares

137,008

Total Value Change

+$36.1M

Total Shares Change

-33,087

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
137,008
+203.5%
$45.9M0.0%$334.79
47
2026-Q1
Decreased
45,149
-34.8%
$14.5M0.0%$322.19
0
2025-Q4
Increased
69,242
+1.6%
$20.4M0.0%$294.74
29
2025-Q3
New
68,141
—
$3.6M0.0%$53.00
37
2025-Q1
Exited
0
-100.0%
$00.0%$37.87
0
2024-Q4
Decreased
58,305
-65.7%
$4.5M0.0%$76.96
0
2024-Q3
Decreased
170,095
-31.5%
$9.8M0.0%$57.83
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used